Preventing reactivation of ocular histoplasmosis: Guidance for patients at risk

Deepe, 2000, Histoplasma capsulatum, 2718 Gass, 1972, Follow-up study of presumed ocular histoplasmosis, Trans Am Acad Ophthalmol Otolaryngol, 76, 672 Schlaegel, 1971, Follow-up study of presumed histoplasmic choroiditis, Am J Ophthalmol, 71, 1192, 10.1016/0002-9394(71)90962-7 Fountain, 1981, Linear streaks of the equator in the presumed ocular histoplasmosis syndrome, Arch Ophthalmol, 99, 246, 10.1001/archopht.1981.03930010248004 Lewis, 1980, Follow-up study of presumed ocular histoplasmosis syndrome, Ophthalmology, 87, 390, 10.1016/S0161-6420(80)35226-3 Smith, 1982, Natural history and reactivation studies of experimental ocular histoplasmosis in a primate model, Trans Am Ophthalmol Soc, 80, 695 Smith, 1971, An epidemiologic study of presumed ocular histoplasmosis, Trans Am Acad Ophthalmol Otolaryngol, 75, 994 Gass, 1972, Follow-up study of presumed ocular histoplasmosis, Trans Am Acad Ophthalmol Otolaryngol, 76, 693 Hawkins, 1994, Risk of visual impairment attributable to ocular histoplasmosis, Arch Ophthalmol, 112, 655, 10.1001/archopht.1994.01090170099031 Olk, 1984, Subfoveal and juxtafoveal subretinal neovacularization in the presumed ocular histoplasmosis syndrome, Ophthalmology, 91, 1592, 10.1016/S0161-6420(84)34113-6 Callanan, 1998, Reactivation of inflammatory lesions in ocular histoplasmosis, Arch Ophthalmol, 116, 470, 10.1001/archopht.116.4.470 Ganley, 1973, Presumed ocular histoplasmosis III, Arch Ophthalmol, 89, 116, 10.1001/archopht.1973.01000040118011 Asbury, 1966, The status of presumed ocular histoplasmosis, Trans Am Ophthalmol Soc, 64, 371 Gass, 1987 1991, Argon laser photocoagulation for neovascular maculopathy, Arch Ophthalmol, 109, 1109, 10.1001/archopht.1991.01080080069030 Fine, 1993, Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome, Arch Ophthalmol, 111, 19, 10.1001/archopht.1993.01090010021006 Rosenfeld, 2004, Photodynamic therapy with verteporfin in ocular histoplasmosis, Ophthalmology, 111, 1725, 10.1016/j.ophtha.2004.02.014 Liu, 2004, Photodynamic therapy of subfoveal and juxtafoveal choroidal neovascularization in ocular histoplasmosis syndrome, Retina, 24, 863, 10.1097/00006982-200412000-00004 2004, Arch Ophthalmol, 122, 1597, 10.1001/archopht.122.11.1597 Fujii, 2001, Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration, Am J Ophthalmol, 131, 90, 10.1016/S0002-9394(00)00769-8 Martidis, 1999, Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization, J Ocul Pharmacol Ther, 15, 425, 10.1089/jop.1999.15.425 D’Amico, 2003, Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration, Ophthalmology, 110, 2372, 10.1016/j.ophtha.2003.08.020 Edwards, 1971, Worldwide pattern of skin sensitivity to histoplasmin, Am J Trop Med Hyg, 20, 288, 10.4269/ajtmh.1971.20.288 Katz, 1997, Acute histoplasmosis choroiditis in 2 immumocompetent brothers, Arch Ophthalmol, 115, 1470, 10.1001/archopht.1997.01100160640023 Scholz, 1984, Histoplasma capsulatum in the eye, Ophthalmology, 91, 1100, 10.1016/S0161-6420(84)34190-2 Spencer, 2003, Detection of Histoplasma capsulatum DNA in lesions of chronic ocular histoplasmosis syndrome, Arch Ophthalmol, 121, 1551, 10.1001/archopht.121.11.1551 Wong, 1973, Focal choroidopathy in experimental ocular histoplasmosis, Trans Am Acad Ophthalmol Otolaryngol, 77, 769 Lenhart, 2004 Ellis, 1973, The geographic localization of presumed ocular histoplasmic choroiditis, Am J Ophthalmol, 75, 953, 10.1016/0002-9394(73)91082-9 Makley, 1965, Presumed histoplasmic choroiditis with special emphasis on modes of therapy, Trans Am Acad Ophthalmol Otolaryngol, 69, 443 Ganley, 1981, Lymphocyte transformation in presumed ocular histoplasmosis, Arch Ophthalmol, 99, 1424, 10.1001/archopht.1981.03930020298021 Check, 1979, Lymphocyte stimulation by yeast phase Histoplasma capsulatum in presumed ocular histoplasmosis syndrome, Am J Ophthalmol, 87, 311, 10.1016/0002-9394(79)90069-2 Meredith, 1980, Association of HLA-DRw2 antigen with presumed ocular histoplasmosis, Am J Ophthalmol, 89, 70, 10.1016/0002-9394(80)90232-9 Meredith, 1978, The prevalence of HLA-B7 in presumed ocular histoplasmosis in patients with peripheral atrophic scars, Am J Ophthalmol, 86, 325, 10.1016/0002-9394(78)90233-7 Dabil, 2003, Association of the HLA-DR15/HLA-DQ6 haplotype with development of choroidal neovascular lesions in presumed ocular histoplasmosis syndrome, Hum Immunol, 64, 960, 10.1016/S0198-8859(03)00175-7 Ongkosuwito, 1999, Aetiological study of the presumed ocular histoplasmosis syndrome in the Netherlands, Br J Ophthalmol, 83, 535, 10.1136/bjo.83.5.535 Watzke, 1998, Histoplasmosis-like choroiditis in a nonendemic area, Retina, 18, 204, 10.1097/00006982-199803000-00003 Woods, 1960, The probable role of benign histoplasmosis in the etiology of granulomatous uveitis, Am J Ophthalmol, 49, 205, 10.1016/0002-9394(60)91515-4 Cohen, 1996, Etiology of choroidal neovascularization in young patients, Ophthalmology, 103, 1241, 10.1016/S0161-6420(96)30515-0 Deepe, 2004, Preventative and therapeutic vaccines for fungal infections, Expert Rev Vaccines, 3, 701, 10.1586/14760584.3.6.701 Fedorovich, 2004, Choroidal neovascularization after laser in situ keratomileusis in a patient with presumed ocular histoplasmosis syndrome, Eur J Ophthalmol, 14, 261, 10.1177/112067210401400312 Pinto, 2004, Choroidal neovascularization following laser in situ keratomileusis, Ophthalmic Surg Lasers Imaging, 35, 63, 10.3928/1542-8877-20040101-14